BLRX Dividende : BioLineRx Ltd. Analyse du rendement



Dividendes

BLRX Dividendes

BioLineRx Ltd.

$3.1

-7.46%

$-0.25

À la fermeture : May 07, 16:00:00 GMT-4

$3.1

Post-Marché: May 07, 20:00:00 GMT-4

Aperçu Prévision Gagner Dividendes Comptes financiers

Statistiques clés

Clôture préc.

$3.35

Prix d'ouverture

$3.29

Plage de la journée

$3.1 - $3.33

Plage de 52 semaines

$2.15 - $7.77

Volume

13.5K

Volume moyen

18.3K

Rendement en dividend

BPA (TTM)

0.00

Capitalisation boursière

$13.4M

Qu’est-ce que BioLineRx Ltd. ?

BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. The company is headquartered in Modiin, Central(Hamerkaz) and currently employs 24 full-time employees. The company went IPO on 2007-01-30. The firm is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The firm is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.